Reference
Institute for Clinical and Economic Review. ICER Publishes White Paper Evaluating Policy Options to Strengthen FDA's Accelerated Approval Pathway for Prescription Drugs. Internet Document : 28 Apr 2021. Available from: URL: https://icer.org/news-insights/press-releases/icer-publishes-white-paper-evaluating-policy-options-to-strengthen-fdas-accelerated-approval-pathway-for-prescription-drugs/
Rights and permissions
About this article
Cite this article
ICER white paper explores policy options to improve accelerated approval pathway. PharmacoEcon Outcomes News 877, 31 (2021). https://doi.org/10.1007/s40274-021-7680-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7680-5